Pharmacokinetic and Efficacy Studies of the Aerosolized PAR2 Antagonist, C781, for the Treatment of Asthma

Activity Type
Research
Date
Dollar Amount
471,411.00
Grant Type
Grant
Principal Investigator
Scott Boitano
Sponsor
PARmedics Inc
Unit
Asthma/Airway Disease Rsch Ctr